Enhancing the Role of Ultrasound with Contrast Agents

[1]  M. Wilchek,et al.  The use of the avidin-biotin complex as a tool in molecular biology. , 2006, Methods of biochemical analysis.

[2]  R. Eckersley,et al.  Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. , 2005, Ultrasound in medicine & biology.

[3]  D O Cosgrove,et al.  Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C , 2004, Gut.

[4]  P. Phillips,et al.  Contrast–agent detection and quantification , 2004, European radiology.

[5]  L Solbiati,et al.  Guidelines for the use of contrast agents in ultrasound. January 2004. , 2004, Ultraschall in der Medizin.

[6]  E. Hahn,et al.  Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver , 2004, European journal of gastroenterology & hepatology.

[7]  Y. Mori,et al.  Renal blood flow measurement with contrast-enhanced harmonic ultrasonography: evaluation of dopamine-induced changes in renal cortical perfusion in humans. , 2003, Clinical nephrology.

[8]  E. Unger,et al.  Targeted-Microbubble Binding Selectively to GPIIb IIIa Receptors of Platelet Thrombi , 2002, Investigative radiology.

[9]  T Aach,et al.  Human cerebral perfusion analysis with ultrasound contrast agent constant infusion: a pilot study on healthy volunteers. , 2002, Ultrasound in medicine & biology.

[10]  P. Phillips,et al.  Contrast pulse sequences (CPS): imaging nonlinear microbubbles , 2001, 2001 IEEE Ultrasonics Symposium. Proceedings. An International Symposium (Cat. No.01CH37263).

[11]  E. Unger,et al.  Gene Delivery Using Ultrasound Contrast Agents , 2001, Echocardiography.

[12]  J. Powers,et al.  Premature Ventricular Contractions During Triggered Imaging With Ultrasound Contrast. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  David O. Cosgrove,et al.  Textbook of Contrast Media , 1999 .

[14]  W. Wagner,et al.  Targeting and ultrasound imaging of microbubble-based contrast agents , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.

[15]  K Moehring,et al.  Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. , 1999, Radiology.

[16]  Thomas Albrecht,et al.  Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.

[17]  H. Rott.  Safety of ultrasonic contrast agents. , 1999, Ultraschall in der Medizin.

[18]  D. Cosgrove,et al.  Functional imaging of tissue response to bolus injection of ultrasound contrast agent , 1998, 1998 IEEE Ultrasonics Symposium. Proceedings (Cat. No. 98CH36102).

[19]  D. Cosgrove,et al.  Echo‐Enhancing (Contrast) Agents , 1998 .

[20]  F. Calliada,et al.  Ultrasound contrast agents: basic principles. , 1998, European journal of radiology.

[21]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[22]  J. Hazel.  Contrast Sonography in Gynaecology , 1997 .

[23]  D. Cosgrove,et al.  Can relative contrast agent concentration be measured in vivo with color Doppler US? , 1997, Radiology.

[24]  P. Burns.  Harmonic imaging with ultrasound contrast agents. , 1996, Clinical radiology.

[25]  K. Tachibana,et al.  Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. , 1995, Circulation.

[26]  N de Jong,et al.  Principles and recent developments in ultrasound contrast agents. , 1991, Ultrasonics.

[27]  R. Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[28]  K. Zierler,et al.  On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.

[29]  D. Eterović,et al.  A critical approach to gamma variate fit of radionuclide-angiography pulmonary histograms , 2004, European Journal of Nuclear Medicine.

[30]  M. Blomley,et al.  The role of ultrasound in molecular imaging. , 2003, The British journal of radiology.

[31]  G. ter Haar.  Ultrasonic contrast agents: safety considerations reviewed. , 2002, European journal of radiology.

[32]  D. Cosgrove,et al.  [Stimulated acoustic emissions with the ultrasound contrast medium levovist: a clinically useful contrast effect with liver-specific properties]. , 2000, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[33]  P. Burns,et al.  Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. , 2000, Investigative radiology.

[34]  D. Cosgrove,et al.  Stimulierte akustische Emission mit dem Ultraschall-Kontrastmittel Levovist: Ein klinisch nutzbarer Kontrasteffekt mit leberspezifischen Eigenschaften , 2000 .

[35]  H. Rott.  Safety of ultrasonic contrast agents. European Committee for Medical Ultrasound Safety. , 1999, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[36]  C. Chin,et al.  Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents , 1999, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[37]  K. Schwarz,et al.  Quantitative echo contrast concentration measurement by Doppler sonography. , 1993, Ultrasound in medicine & biology.

[38]  Brant C. White,et al.  United States patent , 1985 .